Form 4 for JANX Janux Therapeutics, Inc.
Accepted 2026-06-12 20:00:13 ET · period of report 2026-06-11 · accession 0001666963-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-12 20:00 | 2026-06-11 | JANX | Kung Winston | Dir | A - Grant | $0.00 | +5,500 | 11.8K | +88% | $0 |
| D | 2026-06-12 20:00 | 2026-06-11 | JANX | Kung Winston | Dir | A - Grant | $0.00 | +15.5K | 15.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-11 | A | A | 5,500 | $0.00 | 11,750 | D | — | — | (F1) Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of (i) June 11, 2027 and (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the Reporting Person's continuous service on such date. |
| 2 | Derivative | Stock Option (right to buy) | 2026-06-11 | A | A | 15,500 | $0.00 | 15,500 | D | $13.66 · — to 2036-06-10 | 15,500 Common Stock | (F2) The shares subject to the option will vest in equal monthly installments over the 12 months following June 11, 2026, provided that the shares subject to the option will in any case be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on each such date. |